Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Malaria DNA vaccine - Okairos AG

Next Previous
Drug Profile

Malaria DNA vaccine - Okairos AG

Alternative Names: AdCh63 ME-TRAP - Okairos AG; ChAd63 ME-TRAP - Okairos AG; ME-TRAP malaria DNA vaccine - Okairos AG/University of Oxford; MVA ME-TRAP - Okairos AG

Latest Information Update: 16 Aug 2023

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Okairos AG
  • Developer Okairos AG; University of Oxford
  • Class Antimalarials; DNA vaccines; Parasitic vaccines; Vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Malaria

Most Recent Events

  • 06 Sep 2019 University of Oxford and Kenya Medical Research Institute plan a phase IIb trial for Falciparum malaria (Prevention, Combination therapy) in Kenya (IM, Injection), in January 2020 , (NCT03947190)
  • 10 Sep 2018 Discontinued - Phase-II for Malaria (Prevention) in Senegal, United Kingdom, Kenya, Burkina Faso (IM)
  • 09 Sep 2015 Phase-I/II development is ongoing in Burkina Faso

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top